Lamotrigine Tablet
Product Images NDC 67877-167

6 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 67877-167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamo-fig-1 (Lamo Fig 1)

Lamo-fig-1 (Lamo Fig 1)
A Kaplan-Meier survival curve chart showing failure probability over weeks. Two curves compare Lamotrigine and Placebo groups, with failure probability on the Y-axis (0-100%) and time in weeks on the X-axis (0-100). '+' symbols indicate censored data points.*
FDA Label Image

Lamo-fig-2 (Lamo Fig 2)

Lamo-fig-2 (Lamo Fig 2)
A Kaplan-Meier plot showing failure probability (%) over time in weeks for Lamotrigine versus placebo. The graph compares failure probabilities, with the Lamotrigine curve consistently lower than placebo, indicating differences in outcomes between the two groups over approximately 80 weeks.*
FDA Label Image

Lamo-25mg-100tablets (Lamo 25mg 100tablets 21)

Lamo-25mg-100tablets (Lamo 25mg 100tablets 21)
Label for Lamotrigine Tablets USP 25 mg, oral tablet form, manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC. The label includes storage instructions, a caution to verify product dispensation, and indicates 100 tablets per container. The NDC is 67877-164-01.*
FDA Label Image

Lamo-100mg-100tablets (Lamo 100mg 100tablets 21)

Lamo-100mg-100tablets (Lamo 100mg 100tablets 21)
Lamotrigine Tablets USP 100 mg label from Ascend Laboratories, LLC. The label indicates the product is an oral tablet with 100 mg strength, provided in a bottle of 100 tablets. It includes storage instructions, cautions to verify product dispensed, and directions to dispense the Medication Guide to patients. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories in Bedminster, NJ. The label features a barcode and NDC number 67877-165-01.*
FDA Label Image

Lamo-150mg-60tablets (Lamo 150mg 60tablets 21)

Lamo-150mg-60tablets (Lamo 150mg 60tablets 21)
Lamotrigine tablets USP 150 mg oral tablet label by Ascend Laboratories, LLC, containing 60 tablets. The label includes storage instructions, manufacturer Alkem Laboratories Ltd. India, and a barcode. It indicates the product is Rx only and highlights caution to verify product dispensing.*
FDA Label Image

Lamo-200mg-60tablets-21 (Lamo 200mg 60tablets 21)

Lamo-200mg-60tablets-21 (Lamo 200mg 60tablets 21)
Lamotrigine 200 mg tablets label from Ascend Laboratories, LLC. The label indicates 60 scored tablets per bottle, with the active ingredient Lamotrigine USP 200 mg, manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories in New Jersey. Storage instructions and a caution to verify product dispensed are included. The label features a barcode and the NDC 67877-167-60.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.